Yes, Emergent BioSolutions operates as a specialty pharmaceutical and life sciences company focused on developing, manufacturing, and commercializing medical countermeasures and therapeutics. The enterprise centers its core business portfolio heavily on addressing public health threats, infectious diseases, and opioid overdoses—notably producing medical countermeasures for biodefense and the life-saving opioid reversal nasal spray NARCAN, alongside specialized vaccine products for government and commercial healthcare markets.